Outro raises $7 million to expand safe deprescribing platform for psychiatric medications
Outro, a New York-based neuroscience platform that helps patients safely discontinue psychiatric medications, announced it raised $7 million in combined pre-seed and seed funding. The funding will support the company's mission to close America's deprescribing gap and advance research in partnership with academic institutions.
